Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 32 Breast Neoplasms 18 Neoplasms 9 Triple Negative Breast Neoplasms 8 Neoplasm Metastasis 7 Sarcoma 6 Prostatic Neoplasms 6 Fanconi Anemia, Complementation Group D1 6 Pancreatic Neoplasms 5 Endometrial Neoplasms 5 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Small Cell Lung Carcinoma 4 Recurrence 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Fallopian Tube Neoplasms 4 Colorectal Neoplasms 4 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Mesothelioma 2 Head and Neck Neoplasms 2 Glioma 2 Glioblastoma 2 Central Nervous System Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Advanced Solid Tumours 2 Advanced Solid Tumors 2 Wilms Tumor 1

Interventions

Ibandronic Acid 5 Zoledronic Acid 3 Denosumab 3 pembrolizumab 2 Sunitinib 2 Radiotherapy, Intensity-Modulated 2 Nivolumab 2 Methods 2 Interviews as Topic 2 Injections 2 Curettage 2 selinexor 1 saracatinib 1 ridaforolimus 1 radium Ra 223 dichloride 1 pegfilgrastim 1 olaparib 1 montanide ISA 51 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 endostar protein 1 cc-486 1 angiotensin I (1-7) 1 Vincristine 1 Transplantation, Homologous 1 Transplantation, Autologous 1 Transcranial Direct Current Stimulation 1 Trabectedin 1 Tomography, Spiral Computed 1 TES 1 Surveys and Questionnaires 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Bone Neoplasms × olaparib × Clear all

NCT02398058 2021-04-14

TOMAS

Italian Sarcoma Group

Phase 1 Completed

Bone Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡